COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations
The COVID-19 pandemic has brought challenges for people with rheumatic disease in
addition to those faced by the general population, including concerns about higher risks of …
addition to those faced by the general population, including concerns about higher risks of …
Immunological and clinical efficacy of COVID-19 vaccines in immunocompromised populations: a systematic review
S Galmiche, LBL Nguyen, E Tartour… - Clinical Microbiology …, 2022 - Elsevier
Background Available data show that COVID-19 vaccines may be less effective in
immunocompromised populations, who are at increased risk of severe COVID-19 …
immunocompromised populations, who are at increased risk of severe COVID-19 …
Effect of immunosuppression on the immunogenicity of mRNA vaccines to SARS-CoV-2: a prospective cohort study
Background: Patients with chronic inflammatory disease (CID) treated with
immunosuppressive medications have increased risk for severe COVID-19. Although mRNA …
immunosuppressive medications have increased risk for severe COVID-19. Although mRNA …
Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: systematic review and meta-analysis
Objectives The treatment for COVID-19 often utilizes immune-modulating drugs. These
drugs are also used in immune mediated inflammatory diseases (IMIDs). We performed a …
drugs are also used in immune mediated inflammatory diseases (IMIDs). We performed a …
[HTML][HTML] Effectiveness of SARS-CoV-2 mRNA vaccines for preventing Covid-19 hospitalizations in the United States
Background: As SARS-CoV-2 vaccination coverage increases in the United States (US),
there is a need to understand the real-world effectiveness against severe Covid-19 and …
there is a need to understand the real-world effectiveness against severe Covid-19 and …
Evaluation of immune response and disease status in systemic lupus erythematosus patients following SARS–CoV‐2 vaccination
PM Izmirly, MY Kim, M Samanovic… - Arthritis & …, 2022 - Wiley Online Library
Objective To evaluate seroreactivity and disease flares after COVID‐19 vaccination in a
multiethnic/multiracial cohort of patients with systemic lupus erythematosus (SLE). Methods …
multiethnic/multiracial cohort of patients with systemic lupus erythematosus (SLE). Methods …
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups
Autoimmune systemic diseases (ASD) may show impaired immunogenicity to COVID-19
vaccines. Our prospective observational multicenter study aimed to evaluate the …
vaccines. Our prospective observational multicenter study aimed to evaluate the …
Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions …
Background Immunosuppressive treatments inhibit vaccine-induced immunity against SARS-
CoV-2. We evaluated whether a 2-week interruption of methotrexate treatment immediately …
CoV-2. We evaluated whether a 2-week interruption of methotrexate treatment immediately …
Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform …
FPB Kroon, A Najm, A Alunno, JW Schoones… - Annals of the …, 2022 - ard.bmj.com
Objectives Perform a systematic literature review (SLR) on risk and prognosis of SARS-CoV-
2 infection and vaccination against SARS-CoV-2 in patients with rheumatic and …
2 infection and vaccination against SARS-CoV-2 in patients with rheumatic and …
COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses
At the beginning of the COVID-19 pandemic, patients with immune-mediated inflammatory
diseases were considered to be at high risk for SARS-CoV-2 infection and the development …
diseases were considered to be at high risk for SARS-CoV-2 infection and the development …